UNSPSC 85816204: Introduction of insulin into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of insulin into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E030VG

UNSPSC 85816204, Introduction of insulin into peripheral vein, open approach, is a Commodity code that shows little relevant recent activity aligned with its nominal clinical scope. The recent opportunities tagged under this code do not reflect the procedure described; instead, they encompass a broad mix of health services including virtual urgent care, medical director oversight, occupational health screening, cancer registry support, retinal imaging devices, EMS staffing, employee wellness clinics, recovery audit services, telehealth platforms, and opioid use disorder treatment and prevention — none of which involve insulin administration. The code appears to be a labeling or classification mismatch in state and local procurement systems rather than a meaningful procurement category for this specific medical procedure.

State and local issuing bodies posting under this code include health authorities, counties, cities, school districts, and special-purpose health districts across California, Georgia, Nevada, Colorado, Florida, Texas, Kansas, and other states. Recent solicitations span RFIs, RFPs, RFQs, and ITBs, with response deadlines ranging from September through December 2026 and into early 2027. Representative opportunities include Inland Empire Health Plan's virtual urgent care RFI (October 31, 2026 response due), the Nevada Health Authority's PACE operations RFP (December 10, 2026 response due), and San Mateo Medical Center's cancer registry and retinal screening device procurements (October and November 2026 response dates). The geographic spread is national, with no concentration in particular states. The code's recent activity reflects state and local demand for clinical services delivery, health IT platforms, and behavioral health interventions rather than any procurement for the specific insulin administration procedure the code nominally describes.